Corsera Pursues Dual Strategy Against Top Cardiovascular Killer
24 Feb 2026 //
BIOSPACE
Corsera Health Secures $80M Series A, Hits Key Milestone
07 Jan 2026 //
BUSINESSWIRE
Corsera Initiates First Phase 1 Trial For Cardiovascular Disease
27 Oct 2025 //
BUSINESS WIRE
Corsera launches with $50M for predictive AI tool, RNAi Asset
02 Sep 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support